Carfilzomib-Dexamethasone vs Subcutaneous or Intravenous Bortezomib in Relapsed or Refractory Multiple Myeloma: Secondary Analysis of Phase 3 ENDEAVOR Study

• Main Authors: Hartmut Goldschmidt, Philippe Moreau, Heinz Ludwig, Ruben Niesvizky, Wee Joo Chng, Douglas Joshua, Katja Weisel, Andrew Spencer, Robert Orlowski, Shibao Feng, Karim Iskander, Meletios A. Dimopoulos
• Other Authors: MEDICINE
• Format: Others
• Published: Taylor & Francis 2018
• Online Access: http://scholarbank.nus.edu.sg/handle/10635/143070
• Institution: National University of Singapore

10.1080/10428194.2017.1376743